Switching between medications
GLP-1 switching guide
Switching between GLP-1 medications is rarely a 1:1 dose swap. Same-ingredient switches (Ozempic ↔ Wegovy, Mounjaro ↔ Zepbound) usually preserve your current dose. Cross-ingredient switches (semaglutide ↔ tirzepatide) require re-titration. Below are 12 directional guides covering FDA-label dose conversion, side-effect transitions, and insurance considerations.
- Reviewed against FDA labels
- 12 directional guides
Pick your switch direction
All 12 switching guides
semaglutide
Same drug (semaglutide), different FDA indication — for patients who want weight-loss coverage.
Same active ingredientsemaglutide
Same drug, different label — usually a cost / insurance driver, not a clinical one.
Same active ingredienttirzepatide
Same drug (tirzepatide), Zepbound is the weight-loss-labeled version.
Same active ingredienttirzepatide
Same drug, switch when diabetes diagnosis becomes the primary indication.
Same active ingredientsemaglutide → tirzepatide
Type 2 diabetes patients switching from semaglutide to tirzepatide for stronger glycemic control.
Cross-ingredient (re-titrate)tirzepatide → semaglutide
Reverse switch — usually for insurance, side-effect tolerance, or shortage reasons.
Cross-ingredient (re-titrate)semaglutide → tirzepatide
Semaglutide → tirzepatide for weight loss — strongest head-to-head data favors tirzepatide.
Cross-ingredient (re-titrate)tirzepatide → semaglutide
Tirzepatide → semaglutide — typically insurance, side effects, or cost-driven.
Cross-ingredient (re-titrate)semaglutide → tirzepatide
Cross-class switch — same patient often wants weight-loss-labeled drug with stronger effect.
Cross-ingredient (re-titrate)semaglutide → tirzepatide
Patient developed type 2 diabetes — switch from weight-loss-labeled to diabetes-labeled tirzepatide.
Cross-ingredient (re-titrate)tirzepatide → semaglutide
Tirzepatide → semaglutide for weight loss specifically — insurance or formulary driven.
Cross-ingredient (re-titrate)tirzepatide → semaglutide
Cross-class reverse — usually diabetes diagnosis appears and weight-loss coverage drops.
Cross-ingredient (re-titrate)Switching needs prescriber approval
Never switch GLP-1 medications without a prescriber visit. Your provider confirms the indication, writes the new prescription, manages insurance prior authorization, and documents the titration schedule. These guides are educational reference — not a substitute for medical evaluation.
Ready to switch?
Most telehealth providers handle switching prescriptions in 1–3 business days. The ranked providers below process prior authorizations and coordinate with the destination pharmacy.
See top providers for 2026